Cover Image
Market Research Report
Product code
1019728

Legal Cannabis Market Size, Share & Trends Analysis Report By Sources (Marijuana, Hemp), By End-use (Recreational, Medical), By Derivatives (CBD, THC), By Region, And Segment Forecasts, 2021 - 2028

Published: | Grand View Research, Inc. | 150 Pages | Delivery time: 2-10 business days

Price

Back to Top
Legal Cannabis Market Size, Share & Trends Analysis Report By Sources (Marijuana, Hemp), By End-use (Recreational, Medical), By Derivatives (CBD, THC), By Region, And Segment Forecasts, 2021 - 2028
Published: June 22, 2021
Grand View Research, Inc.
Content info: 150 Pages
Delivery time: 2-10 business days
  • ALL
  • Description
  • Table of Contents
Description

Legal Cannabis Market Growth & Trends

The global legal cannabis market size is expected to reach USD 91.5 billion by 2028, registering a CAGR of 26.3% over the forecast period, according to a new report by Grand View Research, Inc. Owing to recent legalization in several parts of the world, the usage of cannabis is gaining momentum for medical purpose. Medical cannabis is used for the treatment of various chronic conditions, such as Parkinson's disease, Alzheimer's disease, arthritis, cancer, depression, anxiety, epilepsy, and other neurological conditions. Thus, a wide application scope has led to an increased product demand for the treatment of various chronic conditions.

In addition, due to cannabis being slowly accepted in various countries, some developed countries, such as Canada, Uruguay, and certain states of the U.S., have gone a step further and legalized the recreational use of cannabis. As recreational cannabis is easily available in the market with an economical price tag, the demand for the same has increased exponentially. This is expected to increase cannabis cultivation to suffice the growing demand. However, the COVID-19 pandemic has adversely affected the market growth owing to the imposition of lockdown, limiting consumers from visiting brick-and-mortar shops.

Based on the sources, the marijuana segment accounted for the highest revenue share in 2020 and is expected to exhibit the fastest growth rate during the forecast period. This can be attributed to increased awareness about its medical benefits and easy availability. For instance, Marijuana oil is used for the treatment of cancer and nausea and can also be used for the improvement of the sleep cycle and alleviating stress, pain, and anxiety. Decriminalization and legalization of medical marijuana in some countries have led to significant shrinkage in the black market.

Moreover, the high efficacy of marijuana-derived CBD is one of the pivotal factors accountable for the segment's large share. The usage of cannabis for medical applications has witnessed an expansion with rising support, among the scientific community, due to its benefits in various treatment processes. In recent years, numerous countries have legalized medical cannabis, but its prescription is dependent on the demand of the patient and physician's preference. The recreational-use segment is expected to be the fastest-growing segment during the forecast period.

Legal Cannabis Market Report Highlights

The market size is anticipated to be valued at USD 91.5 billion by 2028 owing to the increasing legalization of cannabis across the globe

The medical end-use segment dominated the market in 2020 and will retain the leading position during the forecast years

This growth can be credited to the rising geriatric population and increasing demand for cannabis for various medical purposes, such as management of chronic pain, mental disorders, chemotherapy-induced nausea & vomiting, and neurological disorders

North America was the largest regional market in 2020 owing to high demand and positive attitude toward cannabis

Table of Contents
Product Code: GVR-4-68038-278-5

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Research Process
  • 1.2 Information Procurement
    • 1.2.1 Purchased Database:
      • 1.2.1.1 GVR's Internal Database
    • 1.2.2 Market Formulation & Validation
  • 1.3 Research Methodology
  • 1.4 Research Scope and Assumptions
  • 1.5 Research Methodology
    • 1.5.1 Region Market: CAGR Calculation
    • 1.5.2 Region Based Segment Share Calculation
  • 1.6 List to Data Sources

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook
  • 2.3 Competitive Insights
  • 2.4 Global Legal Cannabis Market Snapshot

Chapter 3 Global Legal Cannabis Market Variables, Trends & Scope

  • 3.1 Market Segmentation
  • 3.2 Penetration and Growth Prospect Mapping
  • 3.3 Market Dynamics
    • 3.3.1 Market Driver Analysis
    • 3.3.2 Market Restraint Analysis
  • 3.4 Global Legal Cannabis Industry: History of Medical Use of Cannabis
  • 3.5 Global Legal Cannabis Industry: History of Industrial Use of Cannabis
  • 3.6 Global Legal Cannabis Industry: Number of Clinical Trials, By Region
  • 3.7 Global Legal Cannabis Industry: Legalization Timeline
    • 3.7.1 Legalization Landscape (Timeline)
    • 3.7.2 The U.S. Legalization Landscape
    • 3.7.3 Global Legal Cannabis Regulatory Scenario, By Country
      • 3.7.3.1 The U.S.
      • 3.7.3.1.1 Overview
      • 3.7.3.1.2 Cultivation/Production
      • 3.7.3.1.3 Regulatory Bodies Involved
      • 3.7.3.2 Canada
      • 3.7.3.2.1 Overview
      • 3.7.3.2.2 Cultivation/Production
      • 3.7.3.2.3 Regulatory Bodies Involved
      • 3.7.3.3 Germany
      • 3.7.3.3.1 Overview
      • 3.7.3.3.2 Cultivation/Production
      • 3.7.3.3.3 Regulatory Bodies Involved
      • 3.7.3.4 Italy
      • 3.7.3.4.1 Overview
      • 3.7.3.4.2 Cultivation/Production
      • 3.7.3.4.3 Regulatory Bodies Involved
      • 3.7.3.5 Croatia
      • 3.7.3.5.1 Overview
      • 3.7.3.5.2 Cultivation/Production
      • 3.7.3.5.3 Regulatory Bodies Involved
      • 3.7.3.6 The Netherlands
      • 3.7.3.6.1 Overview
      • 3.7.3.6.2 Cultivation/Production
      • 3.7.3.6.3 Regulatory Bodies Involved
      • 3.7.3.7 Czech Republic
      • 3.7.3.7.1 Overview
      • 3.7.3.7.2 Cultivation/Production
      • 3.7.3.7.3 Regulatory Bodies Involved
      • 3.7.3.8 Poland
      • 3.7.3.8.1 Overview
      • 3.7.3.8.2 Cultivation/Production
      • 3.7.3.8.3 Regulatory Bodies Involved
      • 3.7.3.9 Switzerland
      • 3.7.3.9.1 Overview
      • 3.7.3.9.2 Cultivation/Production
      • 3.7.3.9.3 Regulatory Bodies Involved
      • 3.7.3.10 Australia
      • 3.7.3.10.1 Overview
      • 3.7.3.10.2 Cultivation/Production
      • 3.7.3.10.3 Regulatory Bodies Involved
      • 3.7.3.11 Uruguay
      • 3.7.3.11.1 Overview
      • 3.7.3.11.2 Cultivation/Production
      • 3.7.3.11.3 Regulatory Bodies Involved
      • 3.7.3.12 Colombia
      • 3.7.3.12.1 Overview
      • 3.7.3.12.2 Cultivation/Production
      • 3.7.3.12.3 Regulatory Bodies Involved
      • 3.7.3.13 Argentina
      • 3.7.3.13.1 Overview
      • 3.7.3.13.2 Cultivation/Production
      • 3.7.3.13.3 Regulatory Bodies Involved
      • 3.7.3.14 Chile
      • 3.7.3.14.1 Overview
      • 3.7.3.14.2 Cultivation/Production
      • 3.7.3.14.3 Regulatory Bodies Involved
      • 3.7.3.15 Mexico
      • 3.7.3.15.1 Overview
      • 3.7.3.15.2 Cultivation/Production
      • 3.7.3.15.3 Regulatory Bodies Involved
      • 3.7.3.16 Israel
      • 3.7.3.16.1 Overview
      • 3.7.3.16.2 Cultivation/Production
      • 3.7.3.16.3 Regulatory Bodies Involved
  • 3.8 Global Legal Cannabis Industry: Consumption Pattern Analysis, By Region
    • 3.8.1 Consumption Pattern Analysis, By Region
      • 3.8.1.1 North America
      • 3.8.1.2 Europe
      • 3.8.1.3 Asia Pacific
      • 3.8.1.4 Latin America
      • 3.8.1.5 Mea
    • 3.8.2 Estimated Number of Cannabis Users from 2016 to 2026, By Country
    • 3.8.3 Estimated Number of Medical Marijuana Users from 2016 to 2026, By Country
  • 3.9 Global Legal Cannabis Industry: Potential Trade Opportunity
    • 3.9.1 Trade Opportunity Analysis, By Region
      • 3.9.1.1 North America
      • 3.9.1.2 Europe
      • 3.9.1.3 Asia Pacific
      • 3.9.1.4 Latin America
      • 3.9.1.5 Mea
    • 3.9.2 Global Legal Cannabis Trade Route
    • 3.9.3 Global Hemp Trade Route
    • 3.9.4 Countries Importing and Exporting Medical Cannabis (Flower)
    • 3.9.5 Countries Importing and Exporting Hemp Seeds
    • 3.9.6 Countries Importing and Exporting Hemp Seed Oil
  • 3.10 Global Legal Cannabis Industry: Seed to Shelf Story
    • 3.10.1 Section Description
      • 3.10.1.1 Cultivators and Growers
      • 3.10.1.2 Manufacturers and Producers
      • 3.10.1.3 Testers
      • 3.10.1.4 Wholesalers and Distributors
      • 3.10.1.5 Retailers
    • 3.10.2 Supply Chain Analysis
      • 3.10.2.1 Profit Margin Estimation
  • 3.11 Global Legal Cannabis Industry: Country Case Studies
    • 3.11.1 The U.S.
      • 3.11.1.1 Legalization of Cannabis:
      • 3.11.1.2 Reason for Legalization:
      • 3.11.1.3 Scenario after Legalization and Consumer Attitudes:
      • 3.11.1.4 Competitive Landscape Post Legalization:
    • 3.11.2 Canada
      • 3.11.2.1 Legalization of Cannabis:
      • 3.11.2.2 Reason for Legalization:
      • 3.11.2.3 Scenario after Legalization:
      • 3.11.2.4 Consumer Attitudes toward Legalization:
      • 3.11.2.5 Competitive Landscape Post Legalization:
    • 3.11.3 Thailand
      • 3.11.3.1 Legalization of Cannabis:
      • 3.11.3.2 Licensing and Import/Export Scenario as per Legalization Regulations:
      • 3.11.3.3 Reason for Legalization:
      • 3.11.3.4 Scenario after Legalization:
      • 3.11.3.5 Competitive Landscape Post Legalization:
    • 3.11.4 South Africa
      • 3.11.4.1 Legalization of Cannabis:
      • 3.11.4.2 Reasons for Legalization:
      • 3.11.4.3 Scenario after Legalization:
      • 3.11.4.4 Competitive Landscape Post Legalization:
    • 3.11.5 Uruguay
      • 3.11.5.1 Legalization of Cannabis:
      • 3.11.5.2 Reason for Legalization:
      • 3.11.5.3 Scenario after Legalization:
      • 3.11.5.4 Consumer Attitudes toward Legalization:
    • 3.115.5 Competitive Landscape Post Legalization:

Chapter 4 Global Legal Cannabis Market: Sources Estimates & Trend Analysis

  • 4.1 Segment Dashboard
  • 4.2 Global Legal Cannabis Market: Sources Movement Analysis, 2020 & 2028 (USD Million)
    • 4.2.1 Marijuana
      • 4.2.1.1 Marijuana Market Estimates And Forecasts, 2014 - 2028 (USD Million)
      • 4.2.1.2 Flowers
      • 4.2.1.2.1 Flowers Market Estimates And Forecasts, 2014 - 2028 (USD Million)
      • 4.2.1.3 Oil and Tinctures
      • 4.2.1.3.1 Oil and Tinctures Market Estimates And Forecasts, 2014 - 2028 (USD Million)
    • 4.2.2 Hemp
      • 4.2.2.1 Hemp Market Estimates And Forecasts, 2014 - 2028 (USD Million)
      • 4.2.2.2 Hemp CBD
      • 4.2.2.2.1 Hemp CBD Market Estimates And Forecasts, 2014 - 2028 (USD Million)
      • 4.2.2.3 Supplements
      • 4.2.2.3.1 Supplements Market Estimates And Forecasts, 2014 - 2028 (USD Million)
      • 4.2.2.4 Industrial Hemp
      • 4.2.2.4.1 Industrial Hemp Market Estimates And Forecasts, 2014 - 2028 (USD Million)

Chapter 5 Global Legal Cannabis Market: Derivatives Estimates & Trend Analysis

  • 5.1 Segment Dashboard
  • 5.2 Global Legal Cannabis Market: Derivatives Movement Analysis, 2020 & 2028 (USD Million)
    • 5.2.1 CBD
      • 5.2.1.1 CBD Market Estimates And Forecasts, 2014 - 2028 (USD Million)
    • 5.2.2 THC
      • 5.2.2.1 THC Market Estimates And Forecasts, 2014 - 2028 (USD Million)
    • 5.2.3 Others
      • 5.2.3.1 Others Market Estimates And Forecasts, 2014 - 2028 (USD Million)

Chapter 6 Global Legal Cannabis Market: End-use Estimates & Trend Analysis

  • 6.1 Segment Dashboard
  • 6.2 Global Legal Cannabis Market: End-Use Movement Analysis, 2020 & 2028 (USD Million)
    • 6.2.1 Medical Use
      • 6.2.1.1 Medical Use Market Estimates And Forecasts, 2014 - 2028 (USD Million)
      • 6.2.1.2 Cancer
      • 6.2.1.2.1 Cancer Market Estimates And Forecasts, 2014 - 2028 (USD Million)
      • 6.2.1.3 Chronic Pain
      • 6.2.1.3.1 Chronic Pain Market Estimates And Forecasts, 2014 - 2028 (USD Million)
      • 6.2.1.4 Depression and Anxiety
      • 6.2.1.4.1 Depression and Anxiety Market Estimates And Forecasts, 2014 - 2028 (USD Million)
      • 6.2.1.5 Arthritis
      • 6.2.1.5.1 Arthritis Market Estimates And Forecasts, 2014 - 2028 (USD Million)
      • 6.2.1.6 Diabetes
      • 6.2.1.6.1 Diabetes Market Estimates And Forecasts, 2014 - 2028 (USD Million)
      • 6.2.1.7 Glaucoma
      • 6.2.1.7.1 Glaucoma Market Estimates And Forecasts, 2014 - 2028 (USD Million)
      • 6.2.1.8 Migraines
      • 6.2.1.8.1 Migraines Market Estimates And Forecasts, 2014 - 2028 (USD Million)
      • 6.2.1.9 Epilepsy
      • 6.2.1.9.1 Epilepsy Market Estimates And Forecasts, 2014 - 2028 (USD Million)
      • 6.2.1.10 Multiple Sclerosis
      • 6.2.1.10.1 Multiple Sclerosis Market Estimates And Forecasts, 2014 - 2028 (USD Million)
      • 6.2.1.11 AIDS
      • 6.2.1.11.1 AIDS Market Estimates And Forecasts, 2014 - 2028 (USD Million)
      • 6.2.1.12 Amyotrophic Lateral Sclerosis
      • 6.2.1.12.1 Amyotrophic Lateral Sclerosis Market Estimates And Forecasts, 2014 - 2028 (USD Million)
      • 6.2.1.13 Alzheimer's
      • 6.2.1.13.1 Alzheimer's Market Estimates And Forecasts, 2014 - 2028 (USD Million)
      • 6.2.1.14 Post Traumatic Stress Disorder (PTSD)
      • 6.2.1.14.1 Post Traumatic Stress Disorder (PTSD) Market Estimates And Forecasts, 2014 - 2028 (USD Million)
      • 6.2.1.15 Parkinson's
      • 6.2.1.15.1 Parkinson's Market Estimates And Forecasts, 2014 - 2028 (USD Million)
      • 6.2.1.16 Tourette's
      • 6.2.1.16.1 Tourette's Market Estimates And Forecasts, 2014 - 2028 (USD Million)
      • 6.2.1.17 Others
      • 6.2.1.17.1 Others Market Estimates And Forecasts, 2014 - 2028 (USD Million)
    • 6.2.2 Recreational Use
      • 6.2.2.1 Recreational Use Market Estimates And Forecasts, 2014 - 2028 (USD Million)
    • 6.2.3 Industrial Use
      • 6.2.3.1 Industrial Use Market Estimates And Forecasts, 2014 - 2028 (USD Million)

Chapter 7 Global Legal Cannabis Market: Competitive Analysis

  • 7.1 Company Market Position Analysis
  • 7.2 Strategic Framework

Chapter 8 Global Legal Cannabis Market: Regional Estimates & Trend Analysis: By Product, Sources, and EndUse

  • 8.1 Regional Market Snapshot
  • 8.2 Global Legal Cannabis Market: Regional Movement Analysis, 2020 & 2028 (USD Million)
  • 8.3 North America
    • 8.3.1 North America cannabis market estimates and forecasts, 2014 - 2028 (USD Million)
    • 8.3.2 The U.S.
      • 8.3.2.1 The U.S. cannabis market estimates and forecasts, 2014 - 2028 (USD Million)
    • 8.3.3 Canada
      • 8.3.3.1 Canada cannabis market estimates and forecasts, 2014 - 2028 (USD Million)
  • 8.4 Europe
    • 8.4.1 Europe cannabis market estimates and forecasts, 2014 - 2028 (USD Million)
    • 8.4.2 Germany
      • 8.4.2.1 Germany cannabis market estimates and forecasts, 2014 - 2028 (USD Million)
    • 8.4.3 The U.K.
      • 8.4.3.1The U.K. cannabis market estimates and forecasts, 2014 - 2028 (USD Million)
  • 8.5 Asia
    • 8.5.1 Asia cannabis market estimates and forecasts, 2014 - 2028 (USD Million)
    • 8.5.2 China
      • 8.5.2.1 China cannabis market estimates and forecasts, 2014 - 2028 (USD Million)
    • 8.5.3 India
      • 8.5.3.1 India cannabis market estimates and forecasts, 2014 - 2028 (USD Million)
    • 8.5.4 Japan
      • 8.5.4.1 Japan cannabis market estimates and forecasts, 2014 - 2028 (USD Million)
    • 8.5.5 Thailand
      • 8.5.5.1 Thailand cannabis market estimates and forecasts, 2014 - 2028 (USD Million)
  • 8.6 Oceania
    • 8.6.1 Oceania legal cannabis market estimates and forecasts, 2014 - 2028 (USD Million)
    • 8.6.2 Australia
      • 8.6.2.1 Australia cannabis market estimates and forecasts, 2014 - 2028 (USD Million)
    • 8.6.3 New Zeland
      • 8.6.3.1 New Zeland cannabis market estimates and forecasts, 2014 - 2028 (USD Million)
  • 8.7 Latin America and Caribbean
    • 8.7.1 Latin America and Caribbean legal cannabis market estimates and forecasts, 2014 - 2028 (USD Million)
    • 8.7.2 Brazil
      • 8.7.2.1 Brazil legal cannabis market estimates and forecasts, 2014 - 2028 (USD Million)
    • 8.7.3 Mexico
      • 8.7.3.1 Mexico legal cannabis market estimates and forecasts, 2014 - 2028 (USD Million)
    • 8.7.4 Uruguay
      • 8.7.4.1 Uruguay legal cannabis market estimates and forecasts, 2014 - 2028 (USD Million)
    • 8.7.5 Colombia
      • 8.7.5.1 Colombia legal cannabis market estimates and forecasts, 2014 - 2028 (USD Million)
  • 8.8 Africa
    • 8.8.1 Africa legal cannabis market estimates and forecasts, 2014 - 2028 (USD Million)

Chapter 9 Competitive Landscape

  • 9.1 Company Profiles
    • 9.1.1 Canopy Growth Corporation
      • 9.1.1.1 Funding
      • 9.1.1.2 Number of Employees
      • 9.1.1.3 Headquarters
      • 9.1.1.4 Business Model (Product Offerings)
      • 9.1.1.5 Growers, Manufacturers, Retailers
      • 9.1.1.6 Revenue 2020 (USD Mn)
      • 9.1.1.7 Net Loss 2020 (USD Mn
      • 9.1.1.8 Valuation (USD Mn)
      • 9.1.1.9 Regions With Commercial Presence
    • 9.1.2 GW Pharmaceuticals, PLC
      • 9.1.2.1 Funding
      • 9.1.2.2 Number of Employees
      • 9.1.2.3 Headquarters
      • 9.1.2.4 Business Model (Product Offerings)
      • 9.1.2.5 Growers, Manufacturers, Retailers
      • 9.1.2.6 Revenue 2020 (USD Mn)
      • 9.1.2.7 Net Loss 2020 (USD Mn
      • 9.1.2.8 Valuation (USD Mn)
      • 9.1.2.9 Regions With Commercial Presence
    • 9.1.3 Aurora Cannabis, Inc.
      • 9.1.3.1 Funding
      • 9.1.3.2 Number of Employees
      • 9.1.3.3 Headquarters
      • 9.1.3.4 Business Model (Product Offerings)
      • 9.1.3.5 Growers, Manufacturers, Retailers
      • 9.1.3.6 Revenue 2020 (USD Mn)
      • 9.1.3.7 Net Loss 2020 (USD Mn
      • 9.1.3.8 Valuation (USD Mn)
      • 9.1.3.9 Regions With Commercial Presence
    • 9.1.4 Aphria, Inc. (Prior To Merger With Tilray)
      • 9.1.4.1 Funding
      • 9.1.4.2 Headquarters
      • 9.1.4.3 Business Model (Product Offerings)
      • 9.1.4.4 Growers, Manufacturers, Retailers
      • 9.1.4.5 Valuation (USD Mn)
      • 9.1.4.6 Regions With Commercial Presence
    • 9.1.5 Cronos Group
      • 9.1.5.1 Funding
      • 9.1.5.2 Number of Employees
      • 9.1.5.3 Headquarters
      • 9.1.5.4 Business Model (Product Offerings)
      • 9.1.5.5 Growers, Manufacturers, Retailers
      • 9.1.5.6 Revenue 2020 (USD Mn)
      • 9.1.5.7 Net Loss 2020 (USD Mn
      • 9.1.5.8 Valuation (USD Mn)
      • 9.1.5.9 Regions With Commercial Presence
    • 9.1.6 Tilray
      • 9.1.6.1 Funding
      • 9.1.6.2 Number of Employees
      • 9.1.6.3 Headquarters
      • 9.1.6.4 Business Model (Product Offerings)
      • 9.1.6.5 Growers, Manufacturers, Retailers
      • 9.1.6.6 Revenue 2020 (USD Mn)
      • 9.1.6.7 Net Loss 2020 (USD Mn
      • 9.1.6.8 Valuation (USD Mn)
      • 9.1.6.9 Regions With Commercial Presence
    • 9.1.7 Sundial Growers, Inc.
      • 9.1.7.1 Funding
      • 9.1.7.2 Number of Employees
      • 9.1.7.3 Headquarters
      • 9.1.7.4 Business Model (Product Offerings)
      • 9.1.7.5 Growers, Manufacturers, Retailers
      • 9.1.7.6 Revenue 2020 (USD Mn)
      • 9.1.7.7 Net Loss 2020 (USD Mn
      • 9.1.7.8 Regions With Commercial Presence
    • 9.1.8 Insys Therapeutics, Inc.
      • 9.1.8.1 Funding
      • 9.1.8.2 Number of Employees
      • 9.1.8.3 Headquarters
      • 9.1.8.4 Business Model (Product Offerings)
      • 9.1.8.5 Growers, Manufacturers, Retailers
      • 9.1.8.6 Revenue 2020 (USD Mn)
      • 9.1.8.7 Net Loss 2020 (USD Mn
      • 9.1.8.8 Regions With Commercial Presence
    • 9.1.9 The Scotts Company LLC
      • 9.1.9.1 Number of Employees
      • 9.1.9.2 Headquarters
      • 9.1.9.3 Business Model (Product Offerings)
      • 9.1.9.4 Growers, Manufacturers, Retailers
      • 9.1.9.5 Revenue 2020 (USD Mn)
      • 9.1.9.6 Net Loss 2020 (USD Mn
      • 9.1.9.7 Valuation (USD Mn)
      • 9.1.9.8 Regions With Commercial Presence
    • 9.1.10 Vivo Cannabis Inc.
      • 9.1.10.1 Headquarters
      • 9.1.10.2 Business Model (Product Offerings)
      • 9.1.10.3 Growers, Manufacturers, Retailers
      • 9.1.10.4 Revenue 2020 (USD Mn)
      • 9.1.10.5 Net Loss 2020 (USD Mn
      • 9.1.10.6 Valuation (USD Mn)
      • 9.1.10.7 Regions With Commercial Presence
    • 9.1.11 Cara Therapeutics, Inc.
      • 9.1.11.1 Funding
      • 9.1.11.2 Number of Employees
      • 9.1.11.3 Headquarters
      • 9.1.11.4 Business Model (Product Offerings)
      • 9.1.11.5 Growers, Manufacturers, Retailers
      • 9.1.11.6 Revenue 2020 (USD Mn)
      • 9.1.11.7 Net Loss 2020 (USD Mn
      • 9.1.11.8 Valuation (USD Mn)
      • 9.1.11.9 Regions With Commercial Presence

List of Tables

  • TABLE 1 List of secondary data sources
  • TABLE 2 Cannabis user pool analysis, by country, 2016 - 2026 (in thousands) (18+ years)
  • TABLE 3 Medical marijuana users pool analysis, by country, 2016 - 2026 (in thousands)
  • TABLE 4 North America legal cannabis market, by country, 2014 - 2028 (USD Million)
  • TABLE 5 North America legal cannabis market, by sources, 2014 - 2028 (USD Million)
  • TABLE 6 North America legal marijuana market, by product, 2014 - 2028 (USD Million)
  • TABLE 7 North America hemp market, by product, 2014 - 2028 (USD Million)
  • TABLE 8 North America legal cannabis market, by derivatives, 2014 - 2028 (USD Million)
  • TABLE 9 North America legal cannabis market, by end-use, 2014 - 2028 (USD Million)
  • TABLE 10 North America medical-use market, by medical condition, 2014 - 2028 (USD Million)
  • TABLE 11 The U.S. legal cannabis market, by sources, 2014 - 2028 (USD Million)
  • TABLE 12 The U.S. legal marijuana market, by product, 2014 - 2028 (USD Million)
  • TABLE 13 The U.S. hemp market, by product, 2014 - 2028 (USD Million)
  • TABLE 14 The U.S. legal cannabis market, by derivatives, 2014 - 2028 (USD Million)
  • TABLE 15 The U.S. legal cannabis market, by end-use, 2014 - 2028 (USD Million)
  • TABLE 16 The U.S. medical-use market, by medical condition, 2014 - 2028 (USD Million)
  • TABLE 17 Canada legal cannabis market, by sources, 2014 - 2028 (USD Million)
  • TABLE 18 Canada legal marijuana market, by product, 2014 - 2028 (USD Million)
  • TABLE 19 Canada hemp market, by product, 2014 - 2028 (USD Million)
  • TABLE 20 Canada legal cannabis market, by derivatives, 2014 - 2028 (USD Million)
  • TABLE 21 Canada legal cannabis market, by end-use, 2014 - 2028 (USD Million)
  • TABLE 22 Canada medical-use market, by medical condition, 2014 - 2028 (USD Million)
  • TABLE 23 Europe legal cannabis market, by country, 2014 - 2028 (USD Million)
  • TABLE 24 Europe legal cannabis market, by sources, 2014 - 2028 (USD Million)
  • TABLE 25 Europe legal marijuana market, by product, 2014 - 2028 (USD Million)
  • TABLE 26 Europe hemp market, by product, 2014 - 2028 (USD Million)
  • TABLE 27 Europe legal cannabis market, by derivatives, 2014 - 2028 (USD Million)
  • TABLE 28 Europe legal cannabis market, by end-use, 2014 - 2028 (USD Million)
  • TABLE 29 Europe medical-use market, by medical condition, 2014 - 2028 (USD Million)
  • TABLE 30 Germany legal cannabis market, by sources, 2014 - 2028 (USD Million)
  • TABLE 31 Germany legal marijuana market, by product, 2014 - 2028 (USD Million)
  • TABLE 32 Germany hemp market, by product, 2014 - 2028 (USD Million)
  • TABLE 33 Germany legal cannabis market, by derivatives, 2014 - 2028 (USD Million)
  • TABLE 34 Germany legal cannabis market, by end-use, 2014 - 2028 (USD Million)
  • TABLE 35 Germany medical-use market, by medical condition, 2014 - 2028 (USD Million)
  • TABLE 36 The U.K. legal cannabis market, by sources, 2014 - 2028 (USD Million)
  • TABLE 37 The U.K. legal marijuana market, by product, 2014 - 2028 (USD Million)
  • TABLE 38 The U.K. hemp market, by product, 2014 - 2028 (USD Million)
  • TABLE 39 The U.K. legal cannabis market, by derivatives, 2014 - 2028 (USD Million)
  • TABLE 40 The U.K. legal cannabis market, by end-use, 2014 - 2028 (USD Million)
  • TABLE 41 The U.K. medical-use market, by medical condition, 2014 - 2028 (USD Million)
  • TABLE 42 Asia legal cannabis market, by country, 2014 - 2028 (USD Million)
  • TABLE 43 Asia legal cannabis market, by sources, 2014 - 2028 (USD Million)
  • TABLE 44 Asia legal marijuana market, by product, 2014 - 2028 (USD Million)
  • TABLE 45 Asia market, by product, 2014 - 2028 (USD Million)
  • TABLE 46 Asia legal cannabis market, by derivatives, 2014 - 2028 (USD Million)
  • TABLE 47 Asia legal cannabis market, by end-use, 2014 - 2028 (USD Million)
  • TABLE 48 Asia medical-use market, by medical condition, 2014 - 2028 (USD Million)
  • TABLE 49 China legal cannabis market, by sources, 2014 - 2028 (USD Million)
  • TABLE 50 China legal marijuana market, by product, 2014 - 2028 (USD Million)
  • TABLE 51 China hemp market, by product, 2014 - 2028 (USD Million)
  • TABLE 52 China legal cannabis market, by derivatives, 2014 - 2028 (USD Million)
  • TABLE 53 China legal cannabis market, by end-use, 2014 - 2028 (USD Million)
  • TABLE 54 China medical-use market, by medical condition, 2014 - 2028 (USD Million)
  • TABLE 55 Japan legal cannabis market, by sources, 2014 - 2028 (USD Million)
  • TABLE 56 Japan legal marijuana market, by product, 2014 - 2028 (USD Million)
  • TABLE 57 Japan hemp market, by product, 2014 - 2028 (USD Million)
  • TABLE 58 Japan legal cannabis market, by derivatives, 2014 - 2028 (USD Million)
  • TABLE 59 Japan legal cannabis market, by end-use, 2014 - 2028 (USD Million)
  • TABLE 60 Japan medical-use market, by medical condition, 2014 - 2028 (USD Million)
  • TABLE 61 India legal cannabis market, by sources, 2014 - 2028 (USD Million)
  • TABLE 62 India legal marijuana market, by product, 2014 - 2028 (USD Million)
  • TABLE 63 India hemp market, by product, 2014 - 2028 (USD Million)
  • TABLE 64 India legal cannabis market, by derivatives, 2014 - 2028 (USD Million)
  • TABLE 65 India legal cannabis market, by end-use, 2014 - 2028 (USD Million)
  • TABLE 66 India medical-use market, by medical condition, 2014 - 2028 (USD Million)
  • TABLE 67 Thailand legal cannabis market, by sources, 2014 - 2028 (USD Million)
  • TABLE 68 Thailand legal marijuana market, by product, 2014 - 2028 (USD Million)
  • TABLE 69 Thailand hemp market, by product, 2014 - 2028 (USD Million)
  • TABLE 70 Thailand legal cannabis market, by derivatives, 2014 - 2028 (USD Million)
  • TABLE 71 Thailand legal cannabis market, by end-use, 2014 - 2028 (USD Million)
  • TABLE 72 Thailand medical-use market, by medical condition, 2014 - 2028 (USD Million)
  • TABLE 73 Oceania legal cannabis market, by country, 2014 - 2028 (USD Million)
  • TABLE 74 Oceania legal cannabis market, by sources, 2014 - 2028 (USD Million)
  • TABLE 75 Oceania legal marijuana market, by product, 2014 - 2028 (USD Million)
  • TABLE 76 Oceania hemp market, by product, 2014 - 2028 (USD Million)
  • TABLE 77 Oceania legal cannabis market, by derivatives, 2014 - 2028 (USD Million)
  • TABLE 78 Oceania legal cannabis market, by end-use, 2014 - 2028 (USD Million)
  • TABLE 79 Oceania medical-use market, by medical condition, 2014 - 2028 (USD Million)
  • TABLE 80 Australia legal cannabis market, by sources, 2014 - 2028 (USD Million)
  • TABLE 81 Australia legal marijuana market, by product, 2014 - 2028 (USD Million)
  • TABLE 82 Australia hemp market, by product, 2014 - 2028 (USD Million)
  • TABLE 83 Australia legal cannabis market, by derivatives, 2014 - 2028 (USD Million)
  • TABLE 84 Australia legal cannabis market, by end-use, 2014 - 2028 (USD Million)
  • TABLE 85 Australia medical-use market, by medical condition, 2014 - 2028 (USD Million)
  • TABLE 86 New Zealand legal cannabis market, by sources, 2014 - 2028 (USD Million)
  • TABLE 87 New Zealand legal marijuana market, by product, 2014 - 2028 (USD Million)
  • TABLE 88 New Zealand hemp market, by product, 2014 - 2028 (USD Million)
  • TABLE 89 New Zealand legal cannabis market, by derivatives, 2014 - 2028 (USD Million)
  • TABLE 90 New Zealand legal cannabis market, by end-use, 2014 - 2028 (USD Million)
  • TABLE 91 New Zealand medical-use market, by medical condition, 2014 - 2028 (USD Million)
  • TABLE 92 Latin America and Caribbean legal cannabis market, by country, 2014 - 2028 (USD Million)
  • TABLE 93 Latin America and Caribbean legal cannabis market, by sources, 2014 - 2028 (USD Million)
  • TABLE 94 Latin America and Caribbean legal marijuana market, by product, 2014 - 2028 (USD Million)
  • TABLE 95 Latin America and Caribbean hemp market, by product, 2014 - 2028 (USD Million)
  • TABLE 96 Latin America and Caribbean legal cannabis market, by derivatives, 2014 - 2028 (USD Million)
  • TABLE 97 Latin America and Caribbean legal cannabis market, by end-use, 2014 - 2028 (USD Million)
  • TABLE 98 Latin America and Caribbean medical-use market, by medical condition, 2014 - 2028 (USD Million)
  • TABLE 99 Brazil legal cannabis market, by sources, 2014 - 2028 (USD Million)
  • TABLE 100 Brazil legal marijuana market, by product, 2014 - 2028 (USD Million)
  • TABLE 101 Brazil hemp market, by product, 2014 - 2028 (USD Million)
  • TABLE 102 Brazil legal cannabis market, by derivatives, 2014 - 2028 (USD Million)
  • TABLE 103 Brazil legal cannabis market, by end-use, 2014 - 2028 (USD Million)
  • TABLE 104 Brazil medical-use market, by medical condition, 2014 - 2028 (USD Million)
  • TABLE 105 Mexico legal cannabis market, by sources, 2014 - 2028 (USD Million)
  • TABLE 106 Mexico legal marijuana market, by product, 2014 - 2028 (USD Million)
  • TABLE 107 Mexico hemp market, by product, 2014 - 2028 (USD Million)
  • TABLE 108 Mexico legal cannabis market, by derivatives, 2014 - 2028 (USD Million)
  • TABLE 109 Mexico legal cannabis market, by end-use, 2014 - 2028 (USD Million)
  • TABLE 110 Mexico medical-use market, by medical condition, 2014 - 2028 (USD Million)
  • TABLE 111 Uruguay legal cannabis market, by sources, 2014 - 2028 (USD Million)
  • TABLE 112 Uruguay legal marijuana market, by product, 2014 - 2028 (USD Million)
  • TABLE 113 Uruguay hemp market, by product, 2014 - 2028 (USD Million)
  • TABLE 114 Uruguay legal cannabis market, by derivatives, 2014 - 2028 (USD Million)
  • TABLE 115 Uruguay legal cannabis market, by end-use, 2014 - 2028 (USD Million)
  • TABLE 116 Uruguay medical-use market, by medical condition, 2014 - 2028 (USD Million)
  • TABLE 117 Colombia legal cannabis market, by sources, 2014 - 2028 (USD Million)
  • TABLE 118 Colombia legal marijuana market, by product, 2014 - 2028 (USD Million)
  • TABLE 119 Colombia hemp market, by product, 2014 - 2028 (USD Million)
  • TABLE 120 Colombia legal cannabis market, by derivatives, 2014 - 2028 (USD Million)
  • TABLE 121 Colombia legal cannabis market, by end-use, 2014 - 2028 (USD Million)
  • TABLE 122 Colombia medical-use market, by medical condition, 2014 - 2028 (USD Million)
  • TABLE 123 Africa legal cannabis market, by sources, 2014 - 2028 (USD Million)
  • TABLE 124 Africa legal marijuana market, by product, 2014 - 2028 (USD Million)
  • TABLE 125 Africa hemp market, by product, 2014 - 2028 (USD Million)
  • TABLE 126 Africa legal cannabis market, by derivatives, 2014 - 2028 (USD Million)
  • TABLE 127 Africa legal cannabis market, by end-use, 2014 - 2028 (USD Million)
  • TABLE 128 Africa medical-use market, by medical condition, 2014 - 2028 (USD Million)

List of Figures

  • FIG. 1 Various stages of research workflow
  • FIG. 2 Information procurement
  • FIG. 3 Market Formulation & Validation
  • FIG. 4 Number of clinical trials, by region
  • FIG. 5 Number of clinical trials, by medical conditions
  • FIG. 6 State-wise legalization scenario in the U.S.
  • FIG. 7 Country-wise legalization scenario in Europe
  • FIG. 8 Consumption of cannabis oil for oral use
  • FIG. 9 Percentage of respondents using cannabis edible products and those using products other than edibles
  • FIG. 10 Cannabis consumers (15 to 64 years) (2019)
  • FIG. 11 Cannabis users in Asian countries (Millions) (2019)
  • FIG. 12 Cannabis users in Latin American countries (Millions) (2019)
  • FIG. 13 Global legal marijuana trade route
  • FIG. 14 Global hemp trade route
  • FIG. 15 Supply Chain Network of Hemp Biomass to Industrial applications
  • FIG. 16 Supply chain network of marijuana plant to marijuana oil
  • FIG. 17 Global legal cannabis market, source outlook key takeaways (USD Million)
  • FIG. 18 Global legal cannabis market: source movement analysis, 2020 & 2028 (USD Million)
  • FIG. 19 Marijuana market estimates and forecasts, 2014 - 2028 (USD Million)
  • FIG. 20 Flower market estimates and forecasts, 2014 - 2028 (USD Million)
  • FIG. 21 Oil and tinctures market estimates and forecasts, 2014 - 2028 (USD Million)
  • FIG. 22 Hemp market estimates and forecasts, 2014 - 2028 (USD Million)
  • FIG. 23 Hemp CBD market estimates and forecasts, 2014 - 2028 (USD Million)
  • FIG. 24 Supplements market estimates and forecasts, 2014 - 2028 (USD Million)
  • FIG. 25 Industrial Hemp market estimates and forecasts, 2014 - 2028 (USD Million)
  • FIG. 26 Global legal cannabis market, derivatives outlook key takeaways (USD Million)
  • FIG. 27 Global legal cannabis market: derivatives movement analysis, 2020 & 2028 (USD Million)
  • FIG. 28 CBD market estimates and forecasts, 2014 - 2028 (USD Million)
  • FIG. 29 THC market estimates and forecasts, 2014 - 2028 (USD Million)
  • FIG. 30 Others market estimates and forecasts, 2014 - 2028 (USD Million)
  • FIG. 31 Global legal cannabis market, end use outlook key takeaways (USD Million)
  • FIG. 32 Global legal cannabis market: end use movement analysis, 2020 & 2028 (USD Million)
  • FIG. 33 Global legal cannabis market: proportion of hemp and marijuana by end use (%)
  • FIG. 34 Medical use market estimates and forecasts, 2014 - 2028 (USD Million)
  • FIG. 35 Cancer market estimates and forecasts, 2014 - 2028 (USD Million)
  • FIG. 36 Chronic pain market estimates and forecasts, 2014 - 2028 (USD Million)
  • FIG. 37 Depression and anxiety market estimates and forecasts, 2014 - 2028 (USD Million)
  • FIG. 38 Arthritis market estimates and forecasts, 2014 - 2028 (USD Million)
  • FIG. 39 Diabetes market estimates and forecasts, 2014 - 2028 (USD Million)
  • FIG. 40 Glaucoma market estimates and forecasts, 2014 - 2028 (USD Million)
  • FIG. 41 Migraines market estimates and forecasts, 2014 - 2028 (USD Million)
  • FIG. 42 Epilepsy market estimates and forecasts, 2014 - 2028 (USD Million)
  • FIG. 43 Multiple Sclerosis market estimates and forecasts, 2014 - 2028 (USD Million)
  • FIG. 44 AIDS market estimates and forecasts, 2014 - 2028 (USD Million)
  • FIG. 45 Amyotrophic Lateral Sclerosis market estimates and forecasts, 2014 - 2028 (USD Million)
  • FIG. 46 Alzheimer's market estimates and forecasts, 2014 - 2028 (USD Million)
  • FIG. 47 Post Traumatic Stress Disorder (PTSD) market estimates and forecasts, 2014 - 2028 (USD Million)
  • FIG. 48 Parkinson's market estimates and forecasts, 2014 - 2028 (USD Million)
  • FIG. 49 Tourette's market estimates and forecasts, 2014 - 2028 (USD Million)
  • FIG. 50 Others market estimates and forecasts, 2014 - 2028 (USD Million)
  • FIG. 51 Recreational use market estimates and forecasts, 2014 - 2028 (USD Million)
  • FIG. 52 Industrial use market estimates and forecasts, 2014 - 2028 (USD Million)
  • FIG. 53 Global legal cannabis market, regional outlook key takeaways (USD Million)
  • FIG. 54 Global legal cannabis market: regional movement analysis, 2020 & 2028 (USD Million)
  • FIG. 55 Global legal cannabis market, by revenue and YOY growth
  • FIG. 56 North America legal cannabis market estimates and forecasts, 2014 - 2028 (USD Million)
  • FIG. 57 The U.S. legal cannabis market estimates and forecasts, 2014 - 2028 (USD Million)
  • FIG. 58 Canada legal cannabis market estimates and forecasts, 2014 - 2028 (USD Million)
  • FIG. 59 Europe legal cannabis market estimates and forecasts, 2014 - 2028 (USD Million)
  • FIG. 60 Germany legal cannabis market estimates and forecasts, 2014 - 2028 (USD Million)
  • FIG. 61 The U.K.legal cannabis market estimates and forecasts, 2014 - 2028 (USD Million)
  • FIG. 62 Asia legal cannabis market estimates and forecasts, 2014 - 2028 (USD Million)
  • FIG. 63 China legal cannabis market estimates and forecasts, 2014 - 2028 (USD Million)
  • FIG. 64 India legal cannabis market estimates and forecasts, 2014 - 2028 (USD Million)
  • FIG. 65 Japan legal cannabis market estimates and forecasts, 2014 - 2028 (USD Million)
  • FIG. 66 Oceania legal cannabis market estimates and forecasts, 2014 - 2028 (USD Million)
  • FIG. 67 Australia legal cannabis market estimates and forecasts, 2014 - 2028 (USD Million)
  • FIG. 68 New Zealand legal cannabis market estimates and forecasts, 2014 - 2028 (USD Million)
  • FIG. 69 Latin America and Caribbean legal cannabis market estimates and forecasts, 2014 - 2028 (USD Million)
  • FIG. 70 Brazil legal cannabis market estimates and forecasts, 2014 - 2028 (USD Million)
  • FIG. 71 Mexico legal cannabis market estimates and forecasts, 2014 - 2028 (USD Million)
  • FIG. 72 Uruguay legal cannabis market estimates and forecasts, 2014 - 2028 (USD Million))
  • FIG. 73 Colombia legal cannabis market estimates and forecasts, 2014 - 2028 (USD Million)
  • FIG. 74 Africa legal cannabis market estimates and forecasts, 2014 - 2028 (USD Million)